As Kinder Morgan Del (KMI) Market Value Declined, Consolidated Investment Group Has Cut Its Position; As Acadia Pharmaceuticals (ACAD) Share Value Declined, Knott David M Decreased Its Holding by $1.16 Million

January 19, 2018 - By Kurt Siggers

Knott David M decreased its stake in Acadia Pharmaceuticals Inc. (ACAD) by 98.22% based on its latest 2017Q3 regulatory filing with the SEC. Knott David M sold 30,397 shares as the company’s stock declined 29.10% while stock markets rallied. The institutional investor held 550 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $21,000, down from 30,947 at the end of the previous reported quarter. Knott David M who had been investing in Acadia Pharmaceuticals Inc. for a number of months, seems to be less bullish one the $3.36B market cap company. The stock decreased 2.77% or $0.77 during the last trading session, reaching $27.01. About 1.69M shares traded or 5.79% up from the average. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has declined 15.19% since January 19, 2017 and is downtrending. It has underperformed by 31.89% the S&P500.

Consolidated Investment Group Llc decreased its stake in Kinder Morgan Inc Del (KMI) by 30.59% based on its latest 2017Q3 regulatory filing with the SEC. Consolidated Investment Group Llc sold 50,000 shares as the company’s stock declined 10.34% while stock markets rallied. The institutional investor held 113,465 shares of the public utilities company at the end of 2017Q3, valued at $2.18M, down from 163,465 at the end of the previous reported quarter. Consolidated Investment Group Llc who had been investing in Kinder Morgan Inc Del for a number of months, seems to be less bullish one the $42.41 billion market cap company. The stock decreased 0.11% or $0.02 during the last trading session, reaching $18.99. About 13.42M shares traded. Kinder Morgan, Inc. (NYSE:KMI) has risen 13.09% since January 19, 2017 and is uptrending. It has underperformed by 3.61% the S&P500.

Investors sentiment decreased to 0.77 in Q3 2017. Its down 0.13, from 0.9 in 2017Q2. It turned negative, as 70 investors sold KMI shares while 353 reduced holdings. 69 funds opened positions while 257 raised stakes. 1.31 billion shares or 2.89% more from 1.27 billion shares in 2017Q2 were reported. 364,792 were reported by Public Employees Retirement Association Of Colorado. Dekabank Deutsche Girozentrale owns 769,817 shares. Tower Bridge Advisors invested 0.16% in Kinder Morgan, Inc. (NYSE:KMI). American Century Inc has invested 0% of its portfolio in Kinder Morgan, Inc. (NYSE:KMI). Jefferies Group Lc has invested 0.19% in Kinder Morgan, Inc. (NYSE:KMI). Strs Ohio invested 0.12% of its portfolio in Kinder Morgan, Inc. (NYSE:KMI). Zeke Ltd Liability stated it has 0.09% of its portfolio in Kinder Morgan, Inc. (NYSE:KMI). Carnegie Asset Mgmt Ltd Liability Corporation reported 0.09% stake. Wesbanco National Bank holds 0.04% of its portfolio in Kinder Morgan, Inc. (NYSE:KMI) for 39,200 shares. Caxton Associates Limited Partnership accumulated 1.31 million shares. Indexiq Ltd Llc reported 0.01% of its portfolio in Kinder Morgan, Inc. (NYSE:KMI). Gateway Inv Advisers Ltd Limited Liability Company stated it has 0.02% of its portfolio in Kinder Morgan, Inc. (NYSE:KMI). Lincoln National stated it has 25,208 shares. 2.76 million were accumulated by State Board Of Administration Of Florida Retirement System. Highland Mngmt Lp owns 60,624 shares for 0.05% of their portfolio.

Among 23 analysts covering Kinder Morgan (NYSE:KMI), 13 have Buy rating, 0 Sell and 10 Hold. Therefore 57% are positive. Kinder Morgan had 69 analyst reports since July 30, 2015 according to SRatingsIntel. On Thursday, October 22 the stock rating was downgraded by Stifel Nicolaus to “Hold”. Credit Suisse downgraded the stock to “Neutral” rating in Thursday, October 22 report. RBC Capital Markets maintained Kinder Morgan, Inc. (NYSE:KMI) on Wednesday, October 11 with “Hold” rating. BMO Capital Markets maintained the stock with “Buy” rating in Thursday, October 12 report. The firm has “Outperform” rating by Credit Suisse given on Thursday, January 28. Stifel Nicolaus maintained Kinder Morgan, Inc. (NYSE:KMI) rating on Thursday, July 13. Stifel Nicolaus has “Buy” rating and $2500 target. BMO Capital Markets maintained the stock with “Buy” rating in Thursday, July 27 report. The firm earned “Buy” rating on Sunday, August 16 by Goldman Sachs. The rating was maintained by RBC Capital Markets on Thursday, December 3 with “Outperform”. Barclays Capital maintained it with “Overweight” rating and $25 target in Monday, July 18 report.

Consolidated Investment Group Llc, which manages about $198.00 million US Long portfolio, upped its stake in Newell Brands Inc (NYSE:NWL) by 20,000 shares to 62,500 shares, valued at $2.67 million in 2017Q3, according to the filing.

Knott David M, which manages about $233.95 million US Long portfolio, upped its stake in Coca (NYSE:KO) by 7,600 shares to 13,400 shares, valued at $603,000 in 2017Q3, according to the filing. It also increased its holding in The Kraft Heinz Company by 4,000 shares in the quarter, for a total of 15,900 shares, and has risen its stake in Avadel Pharmaceuticals Plc.

Analysts await ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to report earnings on February, 27. They expect $-0.58 earnings per share, up 10.77% or $0.07 from last year’s $-0.65 per share. After $-0.53 actual earnings per share reported by ACADIA Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts 9.43% negative EPS growth.

Investors sentiment decreased to 1.01 in Q3 2017. Its down 0.04, from 1.05 in 2017Q2. It is negative, as 25 investors sold ACAD shares while 58 reduced holdings. 32 funds opened positions while 52 raised stakes. 113.55 million shares or 1.98% less from 115.85 million shares in 2017Q2 were reported. Baker Bros Advisors Limited Partnership stated it has 25.82 million shares or 7.89% of all its holdings. Teacher Retirement System Of Texas invested in 8,067 shares or 0% of the stock. Stanley, Alabama-based fund reported 143,876 shares. Parkside Bancorp And reported 126 shares. Schwab Charles Inv Mgmt reported 422,605 shares. Geode Cap Management Ltd Limited Liability Company reported 845,130 shares. Canada Pension Plan Board reported 462,200 shares. D E Shaw And Company Inc accumulated 18,429 shares or 0% of the stock. Macquarie invested in 78,810 shares. Creative Planning reported 47,811 shares stake. Gotham Asset Mgmt Limited Liability Corp has invested 0.02% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Emory University holds 1.58% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) for 52,977 shares. 2.00 million are held by Fred Alger Mngmt. Gilder Gagnon Howe Llc has invested 0.07% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Sg Americas Securities Ltd Liability Company reported 4,346 shares.

Among 12 analysts covering ACADIA Pharmaceuticals (NASDAQ:ACAD), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. ACADIA Pharmaceuticals had 33 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has “Buy” rating given on Wednesday, August 9 by Piper Jaffray. The rating was maintained by Jefferies with “Buy” on Monday, September 4. The stock of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) earned “Buy” rating by H.C. Wainwright on Wednesday, August 9. Cowen & Co maintained ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) rating on Sunday, August 9. Cowen & Co has “Outperform” rating and $50 target. The firm has “Buy” rating by Cowen & Co given on Tuesday, November 7. Jefferies maintained ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) on Thursday, July 27 with “Buy” rating. The rating was maintained by Jefferies on Tuesday, October 10 with “Buy”. The rating was downgraded by Piper Jaffray to “Neutral” on Friday, August 7. The stock of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has “Buy” rating given on Thursday, October 5 by Piper Jaffray. The firm has “Buy” rating by JP Morgan given on Friday, September 4.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts